Oppenheimer & Co’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,218
Closed -$669K 1378
2018
Q1
$669K Hold
11,218
0.02% 749
2017
Q4
$684K Hold
11,218
0.02% 750
2017
Q3
$702K Sell
11,218
-2,460
-18% -$159K 0.02% 726
2017
Q2
$959K Hold
13,678
0.03% 611
2017
Q1
$975K Hold
13,678
0.03% 587
2016
Q4
$1.04M Hold
13,678
0.03% 545
2016
Q3
$903K Hold
13,678
0.03% 608
2016
Q2
$886K Hold
13,678
0.03% 583
2016
Q1
$852K Sell
13,678
-425
-3% -$26.5K 0.03% 586
2015
Q4
$870K Buy
14,103
+3,678
+35% +$238K 0.03% 593
2015
Q3
$635K Hold
10,425
0.02% 720
2015
Q2
$678K Buy
+10,425
New +$662K 0.02% 753

Other funds holding NHC

Oppenheimer & Co's NHC Position: Q2 2018 in Review

Oppenheimer & Co sold out of National Healthcare (NHC) in Q2 2018, closing a stake of 11,218 shares — an estimated $669K sold.

Oppenheimer & Co first reported a position in NHC in Q2 2015 and held it in 12 quarters. The position peaked at $1.04M in Q4 2016. 118 funds tracked by Wall St. Rank hold NHC as of Q2 2018.

  • Oppenheimer & Co reported no remaining National Healthcare position as of Q2 2018 after selling out during the quarter.
  • Oppenheimer & Co sold 11,218 National Healthcare shares in Q2 2018, an estimated $669K.
  • Oppenheimer & Co first reported a position in National Healthcare in Q2 2015 and held it in 12 quarters.
  • Oppenheimer & Co's National Healthcare position peaked at $1.04M in Q4 2016.
  • 118 funds tracked by Wall St. Rank held National Healthcare as of Q2 2018.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.